Intravenous fluid study illustrates powerful, efficient approach for comparative clinical trials
Peer-Reviewed Publication
Updates every hour. Last Updated: 15-Aug-2025 03:10 ET (15-Aug-2025 07:10 GMT/UTC)
A clinical trial led by researchers at The Ottawa Hospital and the University of Ottawa and published in the New England Journal of Medicine illustrates a powerful and efficient approach for comparing different standard treatments. The FLUID trial compared two intravenous fluids that have been commonly used for decades in hospitalized patients: normal saline and Ringer's lactate. Many millions of litres of these fluids are used every year in Canada alone, and there is no strong evidence favouring one over the other across the hospital.
An international study published today in the New England Journal of Medicine sheds light on acute normovolemic hemodilution, also known as ANH, a blood conservation technique. ANH involves removing a patient’s blood before the patient goes on heart-lung bypass, and then reinfusing it toward the end of heart surgery. Long debated for its effectiveness, ANH does not appear to reduce the need for red blood cell transfusion, according to results of the global clinical trial. However, study co-author Kenichi Tanaka, M.D., professor and chair of the Department of Anesthesiology at the University of Oklahoma College of Medicine, said the outcomes necessitate further scrutiny and may not be applicable to U.S. patients.
College students are more likely to vape if their friends frequently talk about electronic cigarettes, according to a new study from The University of Texas at Arlington. The effect is particularly strong in tight-knit friend groups, where regular conversations about vaping are linked to more consistent use.